- Founded
- 2016
- Employees
- 51-100
- Total Funding
- $17.5M
Founded by Drew Mark Pardoll, George Kassiotis, Houman Ashrafian in 2016.
About Enara Bio
Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients with solid tumors. Our pioneering EDAPT® platform enables us to discover cancer-specific antigens, including HLA-presented and cell surface antigens, from previously uncharted genomic ‘dark matter’. The result is a growing library of Dark Antigens that can address the need for novel, cancer-specific targets in solid tumors.
Leadership at Enara Bio
The team at the top of the org chart.
Anonymous
President & CEO
43 reports
David Watson
Chief Operating Officer
8 reports
Joseph Dukes
Chief Scientific Officer
29 reports
Sophie Papa
Advisor
Stacey Davis
CBO & CFO
1 report
Scott Drutman MD
Chief Medical Officer
Board
Josh Resnick
Director
Mike Dybbs
Director
Robert Ang
Non-executive Director
Adrian Hill
Scientific Advisory Board Member
Sadik Kassim
Scientific Advisory Board Member
George Kassiotis
Scientific Advisory Board Member
Open Jobs at Enara Bio (2)
Similar companies hiring
Top employers in Health Care